Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 31Gastrointestinal 31Thoracic 3Head & Neck 2Gynecologic 2Endocrine 2CNS 2NET 1Genitourinary 1Dermatologic 1Classical hematology 1

Conditions

Anemia 43Anemia, Refractory, with Excess of Blasts 40Leukemia, Myeloid, Acute 38Myelodysplastic Syndromes 36Leukemia 34Neoplasms 29Precursor Cell Lymphoblastic Leukemia-Lymphoma 27Multiple Myeloma 25Thrombocytopenia 23Leukemia, Lymphocytic, Chronic, B-Cell 21Primary Myelofibrosis 20Lymphoma 20Lymphoma, Non-Hodgkin 19Leukemia, Myelomonocytic, Chronic 18Venous Thromboembolism 17Leukemia, Myelogenous, Chronic, BCR-ABL Positive 16Hodgkin Disease 16Myeloproliferative Disorders 15Lymphoma, Mantle-Cell 14Anemia, Aplastic 14Anemia, Refractory 13Lymphoma, Follicular 12Hematologic Neoplasms 12Lymphoma, Large B-Cell, Diffuse 11Congenital Abnormalities 10Neoplasms, Plasma Cell 9Myelodysplastic-Myeloproliferative Diseases 9Lymphoma, Large-Cell, Immunoblastic 9Leukemia, Myeloid, Chronic-Phase 9Burkitt Lymphoma 9

Interventions

ferric carboxymaltose 1Surveys and Questionnaires 1Iron-Dextran Complex 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Terminated × Gastrointestinal Stromal Tumors × Classical hematology × Clear all
NCT02949947 2020-04-06

Efficacy of Ferric Carboxymaltose in Gastrointestinal Stromal Tumor (GIST) Patients With Iron Deficiency Anemia (IDA) Receiving Systemic Therapy

M.D. Anderson Cancer Center

Phase 2 Terminated
3 enrolled 5 charts
Classical hematologyGastrointestinalSarcoma

Plexosarcoma, Anemia, Iron-Deficiency, Gastrointestinal Stromal Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡